background caffeine consumption has been associated with a reduced risk of parkinson diseasethe association is strong and consistent in men but uncertain in women possibly because of an interaction with hormone replacement therapywe sought to confirm these findings using data on parkinson disease incidence in the cps ii nutrition cohort a large prospective study of men and womenmethods we conducted a prospective study of caffeine intake and risk of pd within the cancer prevention study ii nutrition cohortintakes of coffee and other sources of caffeine were assessed at baselineincident cases of pd n  317 197 men and 120 women were confirmed by treating physicians and medical record reviewrelative risks rr were estimated using proportional hazards models adjusting for age smoking and alcohol consumptionresults after adjustment for age smoking and alcohol intake high caffeine consumption was associated with a reduced risk of pdthe relative risk comparing the 5th to the 1st quintile of caffeine intake was 043 ci 026 071 ptrend  0002 in men and 061 95 ci 034 109 p for trend 005 in womenamong women this association was stronger among never users of hormone replacement therapy rr032 than among ever users rr081 pinteraction  015consumption of decaffeinated coffee was not associated with pd riskconclusion findings from this large prospective study of men and women are consistent with a protective effect of caffeine intake on pd incidence with an attenuating influence of hormone replacement therapy in women